InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Alkermes plc.

ALKS Clue Score59
Ireland Fiscal year ends December CIK 0001520262
$40.26 -0.86% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $40.26 +27.49% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue745.7Operating income−208.7Net income−208.4Fiscal year 2017Revenue903.4 +21.1%Operating income−147.9Net income−157.9Fiscal year 2018Revenue1,094.3 +21.1%Operating income−99.1Net income−139.3Fiscal year 2019Revenue1,170.9 +7.0%Operating income−175.5Net income−196.6Fiscal year 2020Revenue1,038.8 −11.3%Operating income−112.4Net income−110.9EPS, diluted−0.70Fiscal year 2021Revenue1,173.8 +13.0%Operating income97.7Net income−48.2EPS, diluted−0.29Fiscal year 2022Revenue1,111.8 −5.3%Operating income−6.1Net income−158.3EPS, diluted−0.97Fiscal year 2023Revenue1,663.4 +49.6%Operating income414.1Net income355.8EPS, diluted2.10Fiscal year 2024Revenue1,557.6 −6.4%Operating income420.6Net income367.1 +3.2%EPS, diluted2.17 +3.3%Fiscal year 2025Revenue1,475.9 −5.2%Operating income254.0Net income241.7 −34.2%EPS, diluted1.43 −34.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 745.7 903.4 1,094.3 1,170.9 1,038.8 1,173.8 1,111.8 1,663.4 1,557.6 1,475.9
Growth +21.1% +21.1% +7.0% −11.3% +13.0% −5.3% +49.6% −6.4% −5.2%
Operating income −208.7 −147.9 −99.1 −175.5 −112.4 97.7 −6.1 414.1 420.6 254.0
Net income −208.4 −157.9 −139.3 −196.6 −110.9 −48.2 −158.3 355.8 367.1 241.7
Growth +3.2% −34.2%
EPS, diluted n/a n/a n/a n/a −0.70 −0.29 −0.97 2.10 2.17 1.43
Growth +3.3% −34.1%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−28.0%Net margin−28.0%Free cash flow margin−14.4%Fiscal year 2017Operating margin−16.4%Net margin−17.5%Free cash flow margin−3.6%Fiscal year 2018Operating margin−9.1%Net margin−12.7%Free cash flow margin2.7%Fiscal year 2019Operating margin−15.0%Net margin−16.8%Free cash flow margin−1.6%Fiscal year 2020Operating margin−10.8%Net margin−10.7%Free cash flow margin3.9%Fiscal year 2021Operating margin8.3%Net margin−4.1%Free cash flow margin6.3%Fiscal year 2022Operating margin−0.5%Net margin−14.2%Free cash flow margin−1.5%Fiscal year 2023Operating margin24.9%Net margin21.4%Free cash flow margin21.2%Fiscal year 2024Operating margin27.0%Net margin23.6%Free cash flow margin26.0%Fiscal year 2025Operating margin17.2%Net margin16.4%Free cash flow margin32.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −28.0% −16.4% −9.1% −15.0% −10.8% 8.3% −0.5% 24.9% 27.0% 17.2%
Net margin −28.0% −17.5% −12.7% −16.8% −10.7% −4.1% −14.2% 21.4% 23.6% 16.4%
Free cash flow margin −14.4% −3.6% 2.7% −1.6% 3.9% 6.3% −1.5% 21.2% 26.0% 32.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−63.8Capital expenditure−43.7Free cash flow−107.5Fiscal year 2017Operating cash flow19.2Capital expenditure−51.3Free cash flow−32.1Fiscal year 2018Operating cash flow99.3Capital expenditure−69.4Free cash flow29.9Fiscal year 2019Operating cash flow72.1Capital expenditure−90.9Free cash flow−18.9 −163.2%Fiscal year 2020Operating cash flow82.8Capital expenditure−42.2Free cash flow40.6Fiscal year 2021Operating cash flow101.7Capital expenditure−28.0Free cash flow73.7 +81.4%Fiscal year 2022Operating cash flow21.0Capital expenditure−38.3Free cash flow−17.2 −123.4%Fiscal year 2023Operating cash flow401.4Capital expenditure−48.0Free cash flow353.3Fiscal year 2024Operating cash flow439.1Capital expenditure−33.5Free cash flow405.6 +14.8%Buybacks−200.3Fiscal year 2025Operating cash flow520.8Capital expenditure−40.4Free cash flow480.3 +18.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −63.8 19.2 99.3 72.1 82.8 101.7 21.0 401.4 439.1 520.8
Capital expenditure −43.7 −51.3 −69.4 −90.9 −42.2 −28.0 −38.3 −48.0 −33.5 −40.4
Free cash flow −107.5 −32.1 29.9 −18.9 40.6 73.7 −17.2 353.3 405.6 480.3
Growth −163.2% +81.4% −123.4% +14.8% +18.4%
Buybacks n/a n/a n/a n/a n/a n/a n/a n/a −200.3 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash186.4Total debt283.7Net cash (debt)−97.3Shareholders’ equity1,209.5Debt to equity0.23Fiscal year 2017Cash191.3Total debt281.4Net cash (debt)−90.1Shareholders’ equity1,202.8Debt to equity0.23Fiscal year 2018Cash266.8Total debt279.3Net cash (debt)−12.5Shareholders’ equity1,171.3Debt to equity0.24Fiscal year 2019Cash203.8Total debt277.1Net cash (debt)−73.4Shareholders’ equity1,085.4Debt to equity0.26Fiscal year 2020Cash273.0Total debt275.0Net cash (debt)−2.0Shareholders’ equity1,067.0Debt to equity0.26Fiscal year 2021Cash337.5Total debt295.8Net cash (debt)41.7Shareholders’ equity1,112.6Debt to equity0.27Fiscal year 2022Cash292.5Total debt293.3Net cash (debt)−0.8Shareholders’ equity1,043.8Debt to equity0.28Fiscal year 2023Cash457.5Total debt290.7Net cash (debt)166.7Shareholders’ equity1,202.7Debt to equity0.24Fiscal year 2024Cash291.1Shareholders’ equity1,465.0Fiscal year 2025Cash388.6Total debt0.0Net cash (debt)388.6Shareholders’ equity1,819.3Debt to equity0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 186.4 191.3 266.8 203.8 273.0 337.5 292.5 457.5 291.1 388.6
Total debt 283.7 281.4 279.3 277.1 275.0 295.8 293.3 290.7 n/a 0.0
Net cash (debt) −97.3 −90.1 −12.5 −73.4 −2.0 41.7 −0.8 166.7 n/a 388.6
Shareholders’ equity 1,209.5 1,202.8 1,171.3 1,085.4 1,067.0 1,112.6 1,043.8 1,202.7 1,465.0 1,819.3
Debt to equity 0.23 0.23 0.24 0.26 0.26 0.27 0.28 0.24 n/a 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
745.7 903.4 1,094.3 1,170.9 1,038.8 1,173.8 1,111.8 1,663.4 1,557.6 1,475.9
Growth +21.1% +21.1% +7.0% −11.3% +13.0% −5.3% +49.6% −6.4% −5.2%
132.1 154.7 176.4 180.4 178.3 197.3 218.1 253.0 245.3 196.5
387.1 412.9 425.4 512.8 394.6 290.9 272.7 270.8 245.3 324.0
374.1 421.6 526.4 599.4 538.8 549.6 590.8 689.8 645.2 701.5
−208.7 −147.9 −99.1 −175.5 −112.4 97.7 −6.1 414.1 420.6 254.0
Growth −106.2% +1.6% −39.6%
−214.4 −143.3 −127.0 −197.1 −96.5 87.7 −31.1 421.5 443.8 291.5
−5.9 14.7 12.3 −0.4 14.3 11.3 2.0 −97.6 71.6 49.8
−208.4 −157.9 −139.3 −196.6 −110.9 −48.2 −158.3 355.8 367.1 241.7
Growth +3.2% −34.2%
Per share
n/a n/a n/a n/a −0.70 −0.30 −0.97 2.14 2.22 1.47
n/a n/a n/a n/a −0.70 −0.29 −0.97 2.10 2.17 1.43
Growth +3.3% −34.1%
n/a n/a n/a n/a 158.8 160.9 163.7 166.2 165.4 164.7
n/a n/a n/a n/a 158.8 164.8 163.7 169.7 169.2 168.7
Growth +3.7% −0.6% +3.7% −0.3% −0.3%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 7.3% a year over five years.
  • The diluted share count rose 6.3% in five years, which is dilution.
  • Operating margin is up 28.0 points on five years ago, at 17.2%.
  • A net loss in 7 of 10 years on file.